Model Medicines
Building Better Medicines with AI
- Business Model
- B2B
- Website
- modelmedicines.com
- Total Funding
- $4.1M
- Last Round
- $4.1M Series ANov 2021
- Rounds
- 2
About
AI-driven drug discovery company using AI to model chemistry and human biology for medicine development.
Summary
Model Medicines is an Artificial Intelligence company. It has raised $4.1M in total across 2 rounds, most recently a $4.1M Series A round in Nov 2021. Investors include 8VC, Irving Investors and Nex Cubed.
Tech & App Stack
5 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Nov 2021
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Neuralink is building a brain-computer interface for medical needs and greater human potential.
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
Biotech venture firm and therapeutics accelerator that invests at seed stage and acts as a drug d...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...